Which hedge funds own AVIR? ATEA PHARMACEUTICALS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
17 tracked hedge funds disclosed a position in AVIR (ATEA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $53.9m in total. The largest holder by portfolio weight is BML Capital Management, LLC at 18.5% of its book. 4 opened a new position this quarter: Spark Investment Management LLC, Graham Capital Management, L.P., Engineers Gate Manager LP, Trexquant Investment LP. 2 exited: Irenic Capital Management LP, Point72 Asset Management, L.P..
17
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
4
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
2
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$297k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$2.3m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$53.9m
Combined value
Sum of the holders' reported positions in the security.
1.4%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.